74 related articles for article (PubMed ID: 32888352)
21. Establishment and functional characterization of the reversibly immortalized mouse glomerular podocytes (imPODs).
Yu X; Chen L; Wu K; Yan S; Zhang R; Zhao C; Zeng Z; Shu Y; Huang S; Lei J; Ji X; Yuan C; Zhang L; Feng Y; Liu W; Huang B; Zhang B; Luo W; Wang X; Liu B; Haydon RC; Luu HH; He TC; Gan H
Genes Dis; 2018 Jun; 5(2):137-149. PubMed ID: 30258943
[TBL] [Abstract][Full Text] [Related]
22. Development and Characterization of a Novel FVB-
Watanabe M; Ishii Y; Hashimoto K; Takimoto HR; Sasaki N
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674390
[TBL] [Abstract][Full Text] [Related]
23. Transcriptomic profile of human iPSC-derived podocyte-like cells exposed to a panel of xenobiotics.
Murphy C; Jennings P; Wilmes A
Toxicol In Vitro; 2024 May; 97():105804. PubMed ID: 38447685
[TBL] [Abstract][Full Text] [Related]
24. Manganese induces podocyte injury through regulating MTDH/ALKBH5/NLRP10 axis: Combined analysis at epidemiology and molecular biology levels.
Liang Q; Jing J; He H; Huang X; Liu J; Wang M; Qi Z; Zhang L; Huang Z; Yan Y; Liu S; Gao M; Zou Y
Environ Int; 2024 May; 187():108672. PubMed ID: 38648691
[TBL] [Abstract][Full Text] [Related]
25. Cuproptosis associated cytoskeletal destruction contributes to podocyte injury in chronic kidney disease.
Li H; Fu Y; Xu Y; Miao H; Wang H; Zhang T; Mei X; He Y; Zhang A; Ge X
Am J Physiol Cell Physiol; 2024 May; ():. PubMed ID: 38798269
[TBL] [Abstract][Full Text] [Related]
26. Repurposing drugs for diseases associated with podocyte dysfunction.
Shankland SJ; Jefferson JA; Wessely O
Kidney Int; 2023 Sep; 104(3):455-462. PubMed ID: 37290603
[TBL] [Abstract][Full Text] [Related]
27. Contrasting consequences of podocyte insulin-like growth factor 1 receptor inhibition.
Hurcombe JA; Barrington F; Marchetti M; Betin VMS; Bowen EE; Lay AC; Ni L; Dayalan L; Pope RJP; Brinkkoetter PT; Holzenberger M; Welsh GI; Coward RJM
iScience; 2024 May; 27(5):109749. PubMed ID: 38706850
[TBL] [Abstract][Full Text] [Related]
28. Cannabinoid receptor type 2 promotes kidney fibrosis through orchestrating β-catenin signaling.
Zhou S; Wu Q; Lin X; Ling X; Miao J; Liu X; Hu C; Zhang Y; Jia N; Hou FF; Liu Y; Zhou L
Kidney Int; 2021 Feb; 99(2):364-381. PubMed ID: 33152447
[TBL] [Abstract][Full Text] [Related]
29. Stem/progenitor cell in kidney: characteristics, homing, coordination, and maintenance.
Huang J; Kong Y; Xie C; Zhou L
Stem Cell Res Ther; 2021 Mar; 12(1):197. PubMed ID: 33743826
[TBL] [Abstract][Full Text] [Related]
30. Fibrillin-1-enriched microenvironment drives endothelial injury and vascular rarefaction in chronic kidney disease.
Li L; Liao J; Yuan Q; Hong X; Li J; Peng Y; He M; Zhu H; Zhu M; Hou FF; Fu H; Liu Y
Sci Adv; 2021 Jan; 7(5):. PubMed ID: 33571112
[TBL] [Abstract][Full Text] [Related]
31. Matrix metalloproteinase-10 protects against acute kidney injury by augmenting epidermal growth factor receptor signaling.
Hu C; Zuo Y; Ren Q; Sun X; Zhou S; Liao J; Hong X; Miao J; Zhou L; Liu Y
Cell Death Dis; 2021 Jan; 12(1):70. PubMed ID: 33436543
[TBL] [Abstract][Full Text] [Related]
32. Atorvastatin Regulates MALAT1/miR-200c/NRF2 Activity to Protect Against Podocyte Pyroptosis Induced by High Glucose.
Zuo Y; Chen L; He X; Ye Z; Li L; Liu Z; Zhou S
Diabetes Metab Syndr Obes; 2021; 14():1631-1645. PubMed ID: 33880049
[TBL] [Abstract][Full Text] [Related]
33. The role of androgen and its related signals in PCOS.
Ye W; Xie T; Song Y; Zhou L
J Cell Mol Med; 2021 Feb; 25(4):1825-1837. PubMed ID: 33369146
[TBL] [Abstract][Full Text] [Related]
34. Cellular Senescence in Kidney Fibrosis: Pathologic Significance and Therapeutic Strategies.
Xu J; Zhou L; Liu Y
Front Pharmacol; 2020; 11():601325. PubMed ID: 33362554
[TBL] [Abstract][Full Text] [Related]
35. Podocyte-derived extracellular vesicles mediate renal proximal tubule cells dedifferentiation via microRNA-221 in diabetic nephropathy.
Su H; Qiao J; Hu J; Li Y; Lin J; Yu Q; Zhen J; Ma Q; Wang Q; Lv Z; Wang R
Mol Cell Endocrinol; 2020 Dec; 518():111034. PubMed ID: 32926967
[TBL] [Abstract][Full Text] [Related]
36. CXCR4 induces podocyte injury and proteinuria by activating β-catenin signaling.
Mo H; Ren Q; Song D; Xu B; Zhou D; Hong X; Hou FF; Zhou L; Liu Y
Theranostics; 2022; 12(2):767-781. PubMed ID: 34976212
[No Abstract] [Full Text] [Related]
37. Insulin-like growth factor 2 mRNA-binding protein 3 promotes kidney injury by regulating β-catenin signaling.
Song D; Shang J; Long Y; Zhong M; Li L; Chen J; Xiang Y; Tan H; Zhu H; Hong X; Hou FF; Fu H; Liu Y
JCI Insight; 2023 Jan; 8(2):. PubMed ID: 36520532
[TBL] [Abstract][Full Text] [Related]
38. Role of miRNA-671-5p in Mediating Wnt/β-Catenin-Triggered Podocyte Injury.
Wang C; Liu J; Zhang X; Chen Q; Bai X; Hong X; Zhou L; Liu Y
Front Pharmacol; 2021; 12():784489. PubMed ID: 35111054
[TBL] [Abstract][Full Text] [Related]
39. Nuclear Receptor Interacting Protein-2 Mediates the Stabilization and Activation of β-Catenin During Podocyte Injury.
Hou Q; Le W; Kan S; Shi J; Lang Y; Liu Z; Chen Z
Front Cell Dev Biol; 2021; 9():781792. PubMed ID: 35004680
[No Abstract] [Full Text] [Related]
40. MicroRNA-466o-3p mediates β-catenin-induced podocyte injury by targeting Wilms tumor 1.
Chen Q; Chen J; Wang C; Chen X; Liu J; Zhou L; Liu Y
FASEB J; 2020 Nov; 34(11):14424-14439. PubMed ID: 32888352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
